Original Article
Neuropsychopharmacology (2005) 30, 497–507, advance online publication, 28 July 2004; doi:10.1038/sj.npp.1300535
Preclinical Research
Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala
Sachin Patel1, Benjamin F Cravatt2 and Cecilia J Hillard1
- 1Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA
- 2The Skaggs Institute for Chemical Biology and Department of Cell Biology, The Scripps Research Institute, San Diego, CA, USA
Correspondence: Dr CJ Hillard, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. Tel: +1 414 456 8493; Fax: +1 414 456 6545; E-mail: chillard@mcw.edu
Received 11 March 2004; Revised 14 June 2004; Accepted 17 June 2004; Published online 28 July 2004.
Abstract
Anxiety and panic are the most common adverse effects of cannabis intoxication; reactions potentiated by stress. Data suggest that cannabinoid (CB1) receptor modulation of amygdalar activity contributes to these phenomena. Using Fos as a marker, we tested the hypothesis that environmental stress and CB1 cannabinoid receptor activity interact in the regulation of amygdalar activation in male mice. Both 30 min of restraint and CB1 receptor agonist treatment (
9-tetrahydrocannabinol (2.5 mg/kg) or CP55940 (0.3 mg/kg); by i.p. injection) produced barely detectable increases in Fos expression within the central amygdala (CeA). However, the combination of restraint and CB1 agonist administration produced robust Fos induction within the CeA, indicating a synergistic interaction between environmental stress and CB1 receptor activation. An inhibitor of endocannabinoid transport, AM404 (10 mg/kg), produced an additive interaction with restraint within the CeA. In contrast, fatty acid amide hydrolase (FAAH) inhibitor-treated mice (URB597, 1 mg/kg) and FAAH-/- mice did not exhibit any differences in amygdalar activation in response to restraint compared to control mice. In the basolateral (BLA) and medial amygdala, restraint stress produced a low level of Fos induction, which was unaffected by cannabinoid treatment. Interestingly, the CB1 receptor antagonist SR141716 dose-dependently increased Fos expression in the BLA and CeA. These data suggest the CeA is an important neural substrate subserving the interactions between cannabinoids and environmental stress, and could be relevant to understanding the context-dependent emotional and affective changes induced by marijuana intoxication and the role of endocannabinoid signaling in the modulation of amygdalar activity.
Keywords:
marijuana, CB1 receptor, Fos, restraint, FAAH, endocannabinoid, anandamide, 2-AG, anxiety
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Decoding endocannabinoid signaling
Nature Chemical Biology News and Views (01 Jan 2009)
RESEARCH
Neuropsychopharmacology Original Article
Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article

